Bone Marrow-Derived and Elicited Peritoneal Macrophages Are Not Created Equal: The Questions Asked Dictate the Cell Type Used
Open accessAbstract
Macrophages are a heterogeneous and plastic population of cells whose phenotype changes in response to their environment. Macrophage biologists utilize peritoneal (pMAC) and bone marrow-derived macrophages (BMDM) for in vitro studies. Given that pMACs mature in vivo while BMDM are ex vivo differentiated from stem cells, it is likely that their responses differ under experimental conditions. Surprisingly little is known about how BMDM and pMACs responses compare under the same experimental conditionals. While morphologically similar with respect to forward and side scatter by flow cytometry, reports in the literature suggest that pMACs are more mature than their BMDM counterparts. Given the dearth of information comparing BMDM and pMACs, this work was undertaken to test the hypothesis that elicited pMACs are more responsive to defined conditions, including phagocytosis, respiratory burst, polarization, and cytokine and chemokine release. In all cases, our hypothesis was disproved. At steady state, BMDM are more phagocytic (both rate and extent) than elicited pMACs. In response to polarization, they upregulate chemokine and cytokine gene expression and release more cytokines. The results demonstrate that BMDM are generally more responsive and poised to respond to their environment, while pMAC responses are, in comparison, less pronounced. BMDM responses are a function of intrinsic differences, while pMAC responses reflect their differentiation in the context of the whole animal. This distinction may be important in knockout animals, where the pMAC phenotype may be influenced by the absence of the gene of interest.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Peritoneal macrophages differentiate within the tissue, allowing them to mold to their environment and experience hormonal changes throughout the animal's lifespan.
“This population was selected over bone-marrow derived macrophages as peritoneal macrophages differentiate within the tissue, which allows them to mold to their environment and experience hormonal changes throughout the animal’s lifespan [29, 31, 32].”
From Alzheimer’s disease-associated protective variant Plcg2-P522R modulates peripheral macrophage function in a sex-dimorphic manner (2024) · cites this paper as [31]
The Introduction and Discussion state that peritoneal macrophages differentiate in vivo and that their phenotype is shaped by the animal’s environment. Our copy does not say that they experience hormonal changes throughout the animal’s lifespan, so that specific part of the claim is unsupported. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Two physically, functionally, and developmentally distinct peritoneal macrophage subsets
Ghosn, E. E. B., Cassado, A. A., Govoni, G. R., Fukuhara, T., Yang, Y., Monack, D. M., Bortoluci, K. R., Almeida, S. R., Herzenberg, L. A., & Herzenberg, L. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915000107 · Cited by 689 · see citing works
Tan, H.-Y., Wang, N., Li, S., Hong, M., Wang, X., & Feng, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2795090 · Cited by 657 · see citing works
Characterization of murine macrophages from bone marrow, spleen and peritoneum
Wang, C., Yu, X., Cao, Q., Wang, Y., Zheng, G., Tan, T. K., Zhao, H., Zhao, Y., Wang, Y., & Harris, D. C. (2013) · BMC Immunology · doi:10.1186/1471-2172-14-6 · Cited by 225 · see citing works
Flagged first, then by citations
Research works printed but not linked: 36
- [2]Chen R Isolation and culture of mouse bone marrow-derived macrophages (BMM'phi'). Bio-Protocol. (2012) 2: e68 10.21769/BioProtoc.68 · DOI
- [4]Lee CM Hu J. Cell density during differentiation can alter the phenotype of bone marrow-derived macrophages. Cell Biosci. (2013) 3: 30. 10.1186/2045-3701-3-30 23895502 PMC3750618 · DOI
- [5]Weber K Schilling JD. Distinct lysosome phenotypes influence inflammatory function in peritoneal and bone marrow-derived macrophages. Int J Inflam. (2014) 2014: 154936. 10.1155/2014/154936 25587484 PMC4284938 · DOI
- [6]Bisgaard LS Mogensen CK Rosendahl A Cucak H Nielsen LB Rasmussen SE. Bone marrow-derived and peritoneal macrophages have different inflammatory response to oxLDL and M1/M2 marker expression—implications for atherosclerosis research. Sci Rep. (2016) 6: 35234. 10.1038/srep35234 27734926 PMC5062347 · DOI
- [7]Zhao YL Tian PX Han F Zheng J Xia XX Xue WJ. Comparison of the characteristics of macrophages derived from murine spleen, peritoneal cavity, and bone marrow. J Zhejiang Univ Sci B. (2017) 18: 1055– 63. 10.1631/jzus.B1700003 29204985 PMC5742288 · DOI
- [8]Misharin AV Saber R Perlman H. Eosinophil contamination of thioglycollate-elicited peritoneal macrophage cultures skews the functional readouts of in vitro assays. J Leukoc Biol. (2012) 92: 325– 31. 10.1189/jlb.1111560 22706315 PMC3395415 · DOI · Paper page
- [9]Mosser DM Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. (2008) 8: 958– 69. 10.1038/nri2448 19029990 PMC2724991 · DOI · Paper page
- [10]Mantovani Sica A Sozzani S Allavena P Vecchi A Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. (2004) 25: 677– 86. 10.1016/j.it.2004.09.015 15530839 · DOI · Paper page
- [11]Li Y Lee PY Sobel ES Narain S Satoh M Segal MS. Increased expression of FcgammaRI/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. Arthritis Res Ther. (2009) 11: R6. 10.1186/ar2591 19144150 PMC2688236 · DOI
- [12]Akinrinmade OA Chetty S Daramola AK Islam MU Thepen T Barth S. CD64: an attractive immunotherapeutic target for M1-type macrophage mediated chronic inflammatory diseases. Biomedicines. (2017) 5: 56. 10.3390/biomedicines5030056 28895912 PMC5618314 · DOI
- [13]Cheeseman KL Ueyama T Michaud TM Kashiwagi K Wang D Flax LA Targeting of PKC-ε during FcγR-dependent phagocytosis requires the εC1B domain and phospholipase C-γ1. Mol Biol Cell. (2006) 17: 799 10.1091/mbc.e04-12-1100 16319178 PMC1356590 · DOI
- [14]Larsen EC Ueyama T Brannock PM Shirai Y Saito N Larsson C A role for PKC-varepsilon in FcgammaR-mediated phagocytosis by RAW 264.7 cells. J Cell Biol. (2002) 159: 939– 44. 10.1083/jcb.200205140 12499353 PMC2173999 · DOI
- [15]Nimmerjahn F Bruhns P Horiuchi K Ravetch JV. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity. (2005) 23: 41– 51. 10.1016/j.immuni.2005.05.010 16039578 · DOI
- [16]Albanesi M Mancardi DA Macdonald LE Iannascoli B Zitvogel L Murphy AJ. Cutting edge: FcgammaRIII (CD16) and FcgammaRI (CD64) are responsible for anti-glycoprotein 75 monoclonal antibody TA99 therapy for experimental metastatic B16 melanoma. J Immunol. (2012) 189: 5513– 7. 10.4049/jimmunol.1201511 23150715 · DOI
- [18]Gallo P Goncalves R Mosser DM. The influence of IgG density and macrophage Fc (gamma) receptor cross-linking on phagocytosis and IL-10 production. Immunol Lett. (2010) 133: 70– 7. 10.1016/j.imlet.2010.07.004 20670655 PMC2946475 · DOI
- [19]Khallou-Laschet J Varthaman A Fornasa G Compain C Gaston AT Clement M. Macrophage plasticity in experimental atherosclerosis. PLoS ONE. (2010) 5: e8852. 10.1371/journal.pone.0008852 20111605 PMC2810335 · DOI · Paper page
- [20]Gensel JC Kopper TJ Zhang B Orr MB Bailey WM. Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment. Sci Rep. (2017) 7: 40144. 10.1038/srep40144 28057928 PMC5216345 · DOI
- [21]Wu Q Martin RJ Lafasto S Efaw BJ Rino JG Harbeck RJ. Toll-like receptor 2 down-regulation in established mouse allergic lungs contributes to decreased mycoplasma clearance. Am J Respir Crit Care Med. (2008) 177: 720– 9. 10.1164/rccm.200709-1387OC 18202345 · DOI
- [22]Bishayi B Bandyopadhyay D Majhi A Adhikary R. Expression of CXCR1 (interleukin-8 receptor) in murine macrophages after staphylococcus aureus infection and its possible implication on intracellular survival correlating with cytokines and bacterial anti-oxidant enzymes. Inflammation. (2015) 38: 812– 27. 10.1007/s10753-014-9991-1 25129059 · DOI
- [23]Griffin FM Silverstein SC. Segmental response of the macrophage plasma membrane to a phagocytic stimulus. J Exp Med. (1974) 139: 323– 36. 10.1084/jem.139.2.323 4149357 PMC2139535 · DOI
- [24]Griffin FM Griffin JA Leider JE Silverstein SC. Studies on the mechanism of phagocytosis I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane. J Exp Med. (1975) 142: 1263– 82. 10.1084/jem.142.5.1263 1194852 PMC2189973 · DOI
- [25]Griffin FM Griffin JA Silverstein SC. Studies on the mechanism of phagocytosis II. The interaction of macrophages with anti-immunoglobulin IgG-coated bone marrow-derived lymphocytes. J Exp Med. (1976) 144: 788– 809. 10.1084/jem.144.3.788 1085341 PMC2190417 · DOI
- [26]Michl J Silverstein SC. Role of macrophage receptors in the ingestion phase of phagocytosis. Birth Defects Orig Artic Ser. (1978) 14: 99– 117. 346086
- [27]Johnston PA Adams DO Hamilton TA. Regulation of the Fc-receptor-mediated respiratory burst: treatment of primed murine peritoneal macrophages with lipopolysaccharide selectively inhibits H2O2 secretion stimulated by immune complexes. J Immunol. (1985) 135: 513– 8. 3998471
- [28]Brozna JP Hauff NF Phillips WA Johnston RB. Activation of the respiratory burst in macrophages. J Immunol. (1988) 141: 1642– 7. 3411128
- [29]Underhill DM Ozinsky A Hajjar AM Stevens A Wilson CB Bassetti M. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. (1999) 401: 811– 5. 10.1038/44605 10548109 · DOI
- [30]Tacke F Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology. (2006) 211: 609– 18. 10.1016/j.imbio.2006.05.025 16920499 · DOI · Paper page
- [31]Hesketh M Sahin KB West ZE Murray RZ. Macrophage phenotypes regulate scar formation and chronic wound healing. Int J Mol Sci. (2017) 18: e1545. 10.3390/ijms18071545 28714933 PMC5536033 · DOI · Paper page
- [32]Nimmerjahn F Lux A Albert H Woigk M Lehmann C Dudziak D. FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo. Proc Natl Acad Sci USA. (2010) 107: 19396– 401. 10.1073/pnas.1014515107 20974962 PMC2984189 · DOI
- [33]Larsen EC DiGennaro JA Saito N Matha S Loegering DJ Mazurkiewicz JM. Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells. J Immunol. (2000) 165: 2809– 17. 10.4049/jimmunol.165.5.2809 10946313 · DOI
- [34]Hanes CM D'Amico AE Ueyama T Wong AC Zhang X Hynes WF. Golgi-associated protein kinase C-epsilon is delivered to phagocytic cups: role of phosphatidylinositol 4-phosphate. J Immunol. (2017) 199: 271– 7. 10.4049/jimmunol.1700243 28539432 PMC5505341 · DOI
- [35]Wood TR Chow RY Hanes CM Zhang X Kashiwagi K Shirai Y. PKC-epsilon pseudosubstrate and catalytic activity are necessary for membrane delivery during IgG-mediated phagocytosis. J Leukoc Biol. (2013) 94: 109– 22. 10.1189/jlb.1212634 23670290 PMC3685018 · DOI
- [36]Jiménez-García L Herránz S Luque A Hortelano S Thioglycollate-elicited peritoneal macrophages preparation and arginase activity measurement in IL-4 stimulated macrophages. Bio-Protocol. (2015) 5: e1585 10.21769/BioProtoc.1585 · DOI
- [37]Schroder K Sweet MJ Hume DA. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology. (2006) 211: 511– 24. 10.1016/j.imbio.2006.05.007 16920490 · DOI · Paper page
- [38]Muller E Christopoulos PF Halder S Lunde A Beraki K Speth M. Toll-like receptor ligands and interferon-gamma synergize for induction of antitumor M1 macrophages. Front Immunol. (2017) 8: 1383. 10.3389/fimmu.2017.01383 29123526 PMC5662546 · DOI
- [39]Ziemba AM Gottipati MK Totsingan F Hanes CM Gross RA Lennartz MR Sophorolipid Butyl ester diacetate does not affect macrophage polarization but enhances astrocytic glial fibrillary acidic protein expression at micromolar concentrations in vitro. ACS Chem Neurosci. (2017) 8: 752– 8. 10.1021/acschemneuro.6b00451 28140557 PMC5563161 · DOI
Cited by
Sorted by citations
The Immunomodulatory Effects of Statins on Macrophages
Sheridan, A., Wheeler-Jones, C. P. D., & Gage, M. C. (2022) · Immuno · doi:10.3390/immuno2020021 · Cited by 48 · see citing works
Staley, H. A., Jernigan, J. E., Bolen, M. L., Titus, A. M., Neighbarger, N., Cole, C., Menees, K. B., Wallings, R. L., & Tansey, M. G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03271-9 · Cited by 9 · see citing works
“Additionally, this population of peripheral macrophages is well characterized, lending to a more informed study that aims to assess tissue-resident macrophages specifically [29, 31, 32].”
Background
- Authors
- Zajd, C. M., Ziemba, A. M., Miralles, G. M., Nguyen, T., Feustel, P. J., Dunn, S. M., Gilbert, R. J., & Lennartz, M. R.
- Affiliations
- Albany Medical College (US)
- Rensselaer Polytechnic Institute (US)
- Corresponding author
- Lennartz, Michelle R.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-02-21
- Volume
- 11
- Pages
- 269-269
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC7047825
- OpenAlex
- W3006732052
- Cited by
- 48
- References
- 3
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 13 · 2023: 6 · 2022: 13 · 2021: 4 · 2020: 3
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Science Foundation (1247271)
- Regeneron Pharmaceuticals
- National Institutes of Health (C32245GG, NIH-R01, NS092754)
- National Institute of Neurological Disorders and Stroke (R01NS092754)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- macrophage heterogeneity, bone marrow-derived macrophages, peritoneal macrophages, macrophage polarization, phagocytosis, respiratory burst, cytokine and chemokine secretion, macrophage plasticity, macrophage differentiation, knockout mouse models
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Female, Humans, Macrophages, Male, Mice, Inbred C57BL, Phagocytosis, Macrophages, Peritoneal, Mice, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review